260 related articles for article (PubMed ID: 17044926)
1. Clinical implications for vascular endothelial growth factor in the lung: friend or foe?
Papaioannou AI; Kostikas K; Kollia P; Gourgoulianis KI
Respir Res; 2006 Oct; 7(1):128. PubMed ID: 17044926
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor and bevacitumab in breast cancer.
Bando H
Breast Cancer; 2007; 14(2):163-73. PubMed ID: 17485901
[TBL] [Abstract][Full Text] [Related]
3. Role of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease.
Kanazawa H
Med Sci Monit; 2007 Nov; 13(11):RA189-195. PubMed ID: 17968307
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular toxicity of new agents.
Maitland ML
Clin Adv Hematol Oncol; 2008 Sep; 6(9):657-9. PubMed ID: 18827788
[No Abstract] [Full Text] [Related]
5. Targeting VEGF in lung cancer.
Das M; Wakelee H
Expert Opin Ther Targets; 2012 Apr; 16(4):395-406. PubMed ID: 22439677
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis as targeted breast cancer therapy.
Hayes DF; Miller K; Sledge G
Breast; 2007 Dec; 16 Suppl 2():S17-9. PubMed ID: 17707641
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal anti-vascular endothelial growth factor antibody reduces fluid volume in an experimental model of inflammatory pleural effusion.
Ribeiro SC; Vargas FS; Antonangelo L; Marchi E; Genofre EH; Acencio MM; Teixeira LR
Respirology; 2009 Nov; 14(8):1188-93. PubMed ID: 19818055
[TBL] [Abstract][Full Text] [Related]
8. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
Ferrara N
Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
[TBL] [Abstract][Full Text] [Related]
9. Is VEGF a potential therapeutic target in asthma?
Smith R
Pneumologia; 2014; 63(4):194, 197-9. PubMed ID: 25665362
[TBL] [Abstract][Full Text] [Related]
10. The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension.
Sakao S; Tatsumi K
Respiration; 2011; 81(3):253-61. PubMed ID: 21116108
[TBL] [Abstract][Full Text] [Related]
11. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension.
Christou H; Yoshida A; Arthur V; Morita T; Kourembanas S
Am J Respir Cell Mol Biol; 1998 Jun; 18(6):768-76. PubMed ID: 9618381
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic treatment of gastrointestinal malignancies.
Salmon JS; Lockhart AC; Berlin J
Cancer Invest; 2005; 23(8):712-26. PubMed ID: 16377590
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2.
Kernt M; Thiele S; Neubauer AS; Koenig S; Hirneiss C; Haritoglou C; Ulbig MW; Kampik A
Retina; 2012 Sep; 32(8):1652-63. PubMed ID: 22466477
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy.
Hsu JY; Wakelee HA
BioDrugs; 2009; 23(5):289-304. PubMed ID: 19754219
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directions.
Rini BI
Clin Cancer Res; 2007 Feb; 13(4):1098-106. PubMed ID: 17317817
[TBL] [Abstract][Full Text] [Related]
16. The involvement of VEGF in endothelial permeability: a target for anti-inflammatory therapy.
Lee YC
Curr Opin Investig Drugs; 2005 Nov; 6(11):1124-30. PubMed ID: 16312133
[TBL] [Abstract][Full Text] [Related]
17. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
Jain RK
Semin Oncol; 2002 Dec; 29(6 Suppl 16):3-9. PubMed ID: 12516032
[TBL] [Abstract][Full Text] [Related]
18. VEGF signal system: the application of antiangiogenesis.
Liang X; Xu F; Li X; Ma C; Zhang Y; Xu W
Curr Med Chem; 2014 Mar; 21(7):894-910. PubMed ID: 24059233
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy.
Ferrara N; Hillan KJ; Novotny W
Biochem Biophys Res Commun; 2005 Jul; 333(2):328-35. PubMed ID: 15961063
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery.
Li Z; Van Bergen T; Van de Veire S; Van de Vel I; Moreau H; Dewerchin M; Maudgal PC; Zeyen T; Spileers W; Moons L; Stalmans I
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5217-25. PubMed ID: 19474408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
